GSK2801
>98%
- Product Code: 62669
CAS:
1619994-68-1
| Molecular Weight: | 371.45 g./mol | Molecular Formula: | C₂₀H₂₁NO₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
GSK2801 is primarily utilized in the field of biomedical research, particularly in the study of epigenetic regulation. It serves as a potent and selective inhibitor of the bromodomain-containing protein BRD9, which is involved in chromatin remodeling and gene expression. Researchers employ GSK2801 to investigate the role of BRD9 in various biological processes, including cancer progression and immune response. By inhibiting BRD9, this compound helps elucidate the mechanisms underlying diseases and aids in the development of targeted therapies. Additionally, GSK2801 is used in high-throughput screening assays to identify potential drug candidates for conditions where BRD9 activity is implicated. Its specificity and efficacy make it a valuable tool in understanding epigenetic pathways and advancing therapeutic innovations.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | light yellow solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | €135.34 |
+
-
|
| 0.050 | 10-20 days | €580.40 |
+
-
|
GSK2801
GSK2801 is primarily utilized in the field of biomedical research, particularly in the study of epigenetic regulation. It serves as a potent and selective inhibitor of the bromodomain-containing protein BRD9, which is involved in chromatin remodeling and gene expression. Researchers employ GSK2801 to investigate the role of BRD9 in various biological processes, including cancer progression and immune response. By inhibiting BRD9, this compound helps elucidate the mechanisms underlying diseases and aids in the development of targeted therapies. Additionally, GSK2801 is used in high-throughput screening assays to identify potential drug candidates for conditions where BRD9 activity is implicated. Its specificity and efficacy make it a valuable tool in understanding epigenetic pathways and advancing therapeutic innovations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :